EUVIMEDEUVIMED entdecken
Crossref

MEF2D Aggravates Hepatic Ischaemia–Reperfusion Injury by Transcriptionally Regulating CXCL1 Through Interacting With NAT10

Zhigao Deng iD, Zhongshan Lu iD, Quanwei Cheng, Liyang Pan iD, Lihua Zhou, Wei Zhou, Chengbiao Xue, Zhongzhong Liu iD, Qifa Ye iD, Rui Zhou iD, Yan Xiong, Shaojun Ye

Liver International · 2025

DOI: 10.1111/liv.70315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Zhigao Deng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver, Nation…. Hauptthemen laut MEDLINE: Reperfusion Injury, MEF2 Transcription Factors, Liver, Chemokine CXCL1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Transformation fund project of scientific and technological achievements, Zhongnan Hospital of Wuhan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hepatic ischaemia–reperfusion injury (IRI), a common complication after hepatectomy and liver transplantation (LT), is a local sterile inflammatory response driven by innate immunity. Myocyte enhancer factor‐2D (MEF2D) plays an important role in immune inflammatory response by transcriptionally activating or inhibiting gene expression, which is tightly associated with the pathogenic progression of hepatic disorders. However, the role of MEF2D in hepatic IRI is still unclear.

Methods

In this study, we measured MEF2D expression in liver tissue from LT patients, mice subjected to hepatic I/R surgery, and hepatocytes challenged by hypoxia/reoxygenation (H/R) treatment. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, tissue pathology, inflammatory cell infiltration, inflammatory factor expression and apoptosis were used to evaluate liver injury and function in these models. We further explored the regulatory mechanisms of MEF2D in the murine liver IRI model by using hepatocyte‐specific MEF2D knockout mice in the liver IRI model.

Results

We observed that MEF2D expression was significantly up‐regulated after liver I/R in both humans and mice. Notably, high MEF2D levels in human I/R liver specimens were strongly associated with poor prognosis after LT. Additionally, hepatocyte‐specific MEF2D deficiency significantly alleviated I/R‐induced liver injury and inhibited the hepatic inflammatory response and apoptosis. Mechanistically, MEF2D interacted with NAT10, which increased the transcriptional activity of MEF2D by acetylating its K279 lysine site, thereby promoting the transcription of CXCL1 . Moreover, inhibition of NAT10 effectively ameliorated hepatic IRI.

Conclusions

NAT10‐induced MEF2D acetylation aggravates hepatic IRI by positively regulating transcription of CXCL1 in hepatocytes, which provides a promising therapeutic target for hepatic IRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryMEF2 Transcription FactorsLiverChemokine CXCL1AnimalsHumansMiceLiver TransplantationMaleMice, KnockoutHepatocytesDisease Models, AnimalMice, Inbred C57BLApoptosisUp-RegulationHepatectomy

Stichwörter der Autor:innen

C‐X‐C motif chemokine ligand 1N‐acetyltransferase 10acetylationhepatic ischemia–reperfusion injurymyocyte enhancer factor‐2Dtranscription

Substanzen

MEF2 Transcription FactorsChemokine CXCL1MEF2D protein, humanCxcl1 protein, mouse

Autor:innen und Institutionen

  • Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Provincial Clinical Research Center for Natural Polymer Biological Liver, National Quality Control Center for Donated Organ Procurement, Institute of…
  • NHC Key Laboratory of Translational Research on Transplantation Medicine, The 3rd Xiangya Hospital of Central South University, Changsha, China.
  • Department of Medical Parasitology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, China.

ORCID-Profile: Zhigao Deng, Zhongshan Lu, Liyang Pan, Zhongzhong Liu, Qifa Ye, Rui Zhou

Förderung

  • National Natural Science Foundation of China
  • Transformation fund project of scientific and technological achievements, Zhongnan Hospital of Wuhan University

Zitieren

APA

Deng, Z., Lu, Z., Cheng, Q., Pan, L., Zhou, L., Zhou, W., Xue, C., Liu, Z., Ye, Q., Zhou, R., Xiong, Y., & Ye, S. (2025). MEF2D Aggravates Hepatic Ischaemia–Reperfusion Injury by Transcriptionally Regulating CXCL1 Through Interacting With NAT10. Liver International. https://doi.org/10.1111/liv.70315

Vancouver

Deng Z, Lu Z, Cheng Q, Pan L, Zhou L, Zhou W, et al. MEF2D Aggravates Hepatic Ischaemia–Reperfusion Injury by Transcriptionally Regulating CXCL1 Through Interacting With NAT10. Liver International. 2025. doi:10.1111/liv.70315

BibTeX
@article{Deng2025,
  author = {Deng, Zhigao and Lu, Zhongshan and Cheng, Quanwei and Pan, Liyang and Zhou, Lihua and Zhou, Wei and Xue, Chengbiao and Liu, Zhongzhong and Ye, Qifa and Zhou, Rui and Xiong, Yan and Ye, Shaojun},
  title = {MEF2D Aggravates Hepatic Ischaemia–Reperfusion Injury by Transcriptionally Regulating CXCL1 Through Interacting With NAT10},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70315}
}
Kostenlos starten →